Beacon Capital Management LLC (Tennessee)’s Regeneron Pharmaceuticals REGN Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6	Closed	-$3.81K	–	1155
2025 Q1	$3.81K	Sell	6 -14	-70%	-$9.63K	﹤0.01%	828
2024 Q4	$14.2K	Hold	20	–	–	﹤0.01%	536
2024 Q3	$21K	Hold	20	–	–	﹤0.01%	482
2024 Q2	$21K	Hold	20	–	–	﹤0.01%	439
2024 Q1	$19.3K	Hold	20	–	–	﹤0.01%	460
2023 Q4	$16.5K	Hold	20	–	–	﹤0.01%	417
2023 Q3	$14.4K	Hold	20	–	–	﹤0.01%	468
2023 Q2	$14.4K	Buy	+20	New	+$15.4K	﹤0.01%	468

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee)'s REGN Position: Q2 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 6 shares — an estimated $3.81K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in REGN in Q2 2023 and held it in 8 quarters. The position peaked at $21K in Q3 2024. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

Beacon Capital Management LLC (Tennessee) reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Beacon Capital Management LLC (Tennessee) sold 6 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $3.81K.
Beacon Capital Management LLC (Tennessee) first reported a position in Regeneron Pharmaceuticals in Q2 2023 and held it in 8 quarters.
Beacon Capital Management LLC (Tennessee)'s Regeneron Pharmaceuticals position peaked at $21K in Q3 2024.
1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q2 2025, filed 17 Jul 2025.